Antibiotic-induced persistence of cytotoxic Staphylococcus aureus in non-phagocytic cells
- PMID: 14729736
- DOI: 10.1093/jac/dkh076
Antibiotic-induced persistence of cytotoxic Staphylococcus aureus in non-phagocytic cells
Abstract
Objectives: After infection of non-phagocytic cells, some Staphylococcus aureus strains are able to survive and kill their host cells. The purpose of this study was to determine the action of various antibiotics on the survival of host cells and/or intracellular S. aureus.
Methods: Murine keratinocyte (PAM212) and fibroblast (mKSA) cell lines were infected with cytotoxic S. aureus and cultured in the presence of various antibiotics at graded concentrations. The viability of host cells was measured 24 h after infection. To determine the bacterial viability within host cells, cellular lysates were prepared and colony forming units were quantified using a spiral plater. Host cells infected with fluorescein isothiocyanate (FITC)-labelled S. aureus were analysed by flow cytometry and microscopy to determine the subcellular localization S. aureus.
Results: Oxacillin, vancomycin, gentamicin, ciprofloxacin and trimethoprim/sulfamethoxazole did not rescue host cells from cell death induced by intracellular S. aureus. In contrast, linezolid, rifampicin, azithromycin, clindamycin, erythromycin and quinupristin/dalfopristin suppressed the cytotoxic action of S. aureus. After withdrawal of antibiotics, intracellular S. aureus regained cytotoxic activity and killed their host cells. Only rifampicin was able to eliminate intracellular S. aureus completely within 72 h. In contrast, clindamycin, azithromycin and linezolid induced a state of intracellular persistence of viable S. aureus.
Conclusions: Antibiotics commonly used for the management of S. aureus infections appear to create a niche for invasive intracellular S. aureus, which may play an important role for persistence and recurrence of infection. Because of its unique ability to eliminate intracellular S. aureus, rifampicin appears to be valuable for the treatment of invasive S. aureus infections.
Similar articles
-
Subinhibitory quinupristin/dalfopristin attenuates virulence of Staphylococcus aureus.J Antimicrob Chemother. 2006 Sep;58(3):564-74. doi: 10.1093/jac/dkl291. J Antimicrob Chemother. 2006. PMID: 16895938
-
Activities of antistaphylococcal antibiotics towards the extracellular and intraphagocytic forms of Staphylococcus aureus isolates from a patient with persistent bacteraemia and endocarditis.Clin Microbiol Infect. 2008 Aug;14(8):766-77. doi: 10.1111/j.1469-0691.2008.02035.x. Clin Microbiol Infect. 2008. PMID: 18727801
-
[The rate of inducible clindamycin resistance and susceptibilities to other antimicrobial agents in staphylococci].Mikrobiyol Bul. 2009 Jan;43(1):37-44. Mikrobiyol Bul. 2009. PMID: 19334378 Turkish.
-
Excretion of antimicrobials used to treat methicillin-resistant Staphylococcus aureus infections during lactation: safety in breastfeeding infants.Pharmacotherapy. 2009 Sep;29(9):1103-9. doi: 10.1592/phco.29.9.1103. Pharmacotherapy. 2009. PMID: 19698015 Review.
-
Antibiotics currently used in the treatment of infections caused by Staphylococcus aureus.Intern Med J. 2005 Dec;35 Suppl 2:S3-16. doi: 10.1111/j.1444-0903.2005.00976.x. Intern Med J. 2005. PMID: 16271060 Review.
Cited by
-
Role of Implantable Drug Delivery Devices with Dual Platform Capabilities in the Prevention and Treatment of Bacterial Osteomyelitis.Bioengineering (Basel). 2022 Feb 6;9(2):65. doi: 10.3390/bioengineering9020065. Bioengineering (Basel). 2022. PMID: 35200418 Free PMC article. Review.
-
In Vitro and Ex Vivo Efficacy of Novel Trp-Arg Rich Analogue of α-MSH against Staphylococcus aureus.ACS Omega. 2020 Feb 17;5(7):3258-3270. doi: 10.1021/acsomega.9b03307. eCollection 2020 Feb 25. ACS Omega. 2020. PMID: 32118141 Free PMC article.
-
In vivo efficacy of anuran trypsin inhibitory peptides against staphylococcal skin infection and the impact of peptide cyclization.Antimicrob Agents Chemother. 2015 Apr;59(4):2113-21. doi: 10.1128/AAC.04324-14. Epub 2015 Jan 26. Antimicrob Agents Chemother. 2015. PMID: 25624332 Free PMC article.
-
Mechanisms of Antibiotic Failure During Staphylococcus aureus Osteomyelitis.Front Immunol. 2021 Feb 12;12:638085. doi: 10.3389/fimmu.2021.638085. eCollection 2021. Front Immunol. 2021. PMID: 33643322 Free PMC article. Review.
-
NOX2 Deficiency Permits Sustained Survival of S. aureus in Macrophages and Contributes to Severity of Infection.Front Immunol. 2021 Mar 22;12:633629. doi: 10.3389/fimmu.2021.633629. eCollection 2021. Front Immunol. 2021. PMID: 33868252 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical